Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Psoriasis
•
Dermatology
How have you incorporated biologics targeting the IL-36 pathway (e.g. Spevigo) into your treatment algorithm for psoriasis?
Related Questions
Do you avoid the use of hydroxychloroquine in patients with psoriasis and/or psoriatic arthritis?
How do you manage a psoriatic patient previously on cimizia and now stelara with new onset atopic dermatitis (with desire for pregnancy and fertility treatments)?
How do you approach treating patients who develop psoriasis while on Dupixent?
What topical therapies have you found most effective for managing scalp psoriasis?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What therapies have you found most effective for managing pustular psoriasis?
How do you approach patients that develop atopic dermatitis while on biologics for psoriasis?
How do you approach management of patients with psoriatic arthritis who have significant improvement in skin disease, but ongoing inflammatory arthritis despite multiple DMARDs and/or biologics?
How does your treatment approach for melasma differ in skin of color patients?
What is your preferred workup for a patient who has a biopsy consistent with “dermal hypersensitivity reaction”?
